drugset / Trial / NCT04094038

The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients

NCT04094038 ↗

Phase 4 Active not recruiting 166 enrolled Erasmus Medical Center Baxter Healthcare Corporation · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Protein-energy wasting (PEW), a hypercatabolic state characterized by loss of muscle mass and fuel reserves, is highly prevalent in hemodialysis patients. Nutritional status and body composition are closely linked to morbidity, mortality and quality of life. Lean tissue mass (LTM) appears to be the best read-out for the association between nutritional status and outcomes. Intradialytic parenteral nutrition (IDPN) is occasionally used with the aim to reduce loss of LTM, but its efficacy has not been established. The goal of this study is to study the effect of IDPN on changes in LTM in hemodialysis patients.

Timeline

Start
2019-09-16
Primary completion
2024-04-02
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Olimel N12 Unknown — —